Iqvia Stock Price, News & Analysis (NYSE:IQV)

$101.72 +0.15 (+0.15 %)
(As of 02/18/2018 04:00 PM ET)
Previous Close$101.72
Today's Range$101.16 - $102.50
52-Week Range$75.94 - $110.67
Volume1.27 million shs
Average Volume1.28 million shs
Market Capitalization$21.16 billion
P/E Ratio16.81
Dividend YieldN/A
Beta0.61

About Iqvia (NYSE:IQV)

Iqvia logoIQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.

Receive IQV News and Ratings via Email

Sign-up to receive the latest news and ratings for IQV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorBusiness Services
SymbolNYSE:IQV
CUSIPN/A
Phone919-998-2000

Debt

Debt-to-Equity Ratio1.21%
Current Ratio1.19%
Quick Ratio1.22%

Price-To-Earnings

Trailing P/E Ratio16.8132231404959
Forward P/E Ratio24.81
P/E Growth1.38

Sales & Book Value

Annual Sales$9.74 billion
Price / Sales2.17
Cash Flow$9.77 per share
Price / Cash10.41
Book Value$40.19 per share
Price / Book2.53

Profitability

Trailing EPS$6.05
Net Income$115 million
Net Margins13.44%
Return on Equity13.03%
Return on Assets4.65%

Miscellaneous

Employees50,000
Outstanding Shares207,990,000

Iqvia (NYSE:IQV) Frequently Asked Questions

What is Iqvia's stock symbol?

Iqvia trades on the New York Stock Exchange (NYSE) under the ticker symbol "IQV."

How were Iqvia's earnings last quarter?

Iqvia Holdings Inc (NYSE:IQV) announced its earnings results on Wednesday, February, 14th. The medical research company reported $1.32 EPS for the quarter, missing the consensus estimate of $1.34 by $0.02. The medical research company had revenue of $2.16 billion for the quarter, compared to the consensus estimate of $2.14 billion. Iqvia had a return on equity of 13.03% and a net margin of 13.44%. The business's quarterly revenue was up 10.7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.09 EPS. View Iqvia's Earnings History.

When will Iqvia make its next earnings announcement?

Iqvia is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Iqvia.

What guidance has Iqvia issued on next quarter's earnings?

Iqvia updated its FY18 earnings guidance on Wednesday, February, 14th. The company provided earnings per share guidance of $5.35-5.60 for the period, compared to the Thomson Reuters consensus estimate of $5.34. The company issued revenue guidance of $8.45-8.65 billion, compared to the consensus revenue estimate of $8.53 billion.Iqvia also updated its Q1 guidance to $1.23-1.30 EPS.

Where is Iqvia's stock going? Where will Iqvia's stock price be in 2018?

16 brokers have issued 1-year price objectives for Iqvia's stock. Their predictions range from $93.42 to $128.00. On average, they anticipate Iqvia's stock price to reach $109.91 in the next year. View Analyst Ratings for Iqvia.

Who are some of Iqvia's key competitors?

Who are Iqvia's key executives?

Iqvia's management team includes the folowing people:

  • Ari Bousbib, Chairman of the Board, President, Chief Executive Officer (Age 56)
  • Michael R. McDonnell, Chief Financial Officer, Executive Vice President (Age 53)
  • Kevin C. Knightly, President - Information and Technology Solutions (Age 55)
  • W. Richard Staub III, President - Research and Development Solutions (Age 54)
  • James H. Erlinger III, Executive Vice President, General Counsel, Secretary (Age 58)
  • Dennis B. Gillings Ph.D., Lead Director (Age 72)
  • John P. Connaughton, Independent Director (Age 54)
  • Jonathan J. Coslet, Independent Director (Age 52)
  • John G. Danhakl, Independent Director (Age 60)
  • Michael J. Evanisko, Independent Director (Age 67)

Who owns Iqvia stock?

Iqvia's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (4.63%), Longview Partners Guernsey LTD (4.56%), Jackson Square Partners LLC (2.28%), Farallon Capital Management LLC (1.42%), Alliancebernstein L.P. (1.24%) and Macquarie Group Ltd. (0.77%). Company insiders that own Iqvia stock include Annie H Lo, Ari Bousbib, Corp 3I, Cpp Investment Board Private H, Dennis B Ph D Gillings, Jack M Greenberg, James H Erlinger III, John Connaughton, John G Danhakl, Kevin C Knightly and Kevin K Gordon. View Institutional Ownership Trends for Iqvia.

Who bought Iqvia stock? Who is buying Iqvia stock?

Iqvia's stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Longview Partners Guernsey LTD, Jackson Square Partners LLC, Farallon Capital Management LLC, Alliancebernstein L.P., Macquarie Group Ltd., Geode Capital Management LLC and Lazard Asset Management LLC. View Insider Buying and Selling for Iqvia.

How do I buy Iqvia stock?

Shares of Iqvia can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Iqvia's stock price today?

One share of Iqvia stock can currently be purchased for approximately $101.72.

How big of a company is Iqvia?

Iqvia has a market capitalization of $21.16 billion and generates $9.74 billion in revenue each year. The medical research company earns $115 million in net income (profit) each year or $6.05 on an earnings per share basis. Iqvia employs 50,000 workers across the globe.

How can I contact Iqvia?

Iqvia's mailing address is 4820 EMPEROR BLVD., DURHAM NC, 27703. The medical research company can be reached via phone at 919-998-2000 or via email at [email protected]


MarketBeat Community Rating for Iqvia (IQV)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  305 (Vote Outperform)
Underperform Votes:  268 (Vote Underperform)
Total Votes:  573
MarketBeat's community ratings are surveys of what our community members think about Iqvia and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Iqvia (NYSE:IQV) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.592.592.502.38
Ratings Breakdown: 0 Sell Rating(s)
7 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
10 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
10 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $109.91$107.53$102.16$89.49
Price Target Upside: 8.21% upside7.29% upside1.81% downside1.86% downside

Iqvia (NYSE:IQV) Consensus Price Target History

Price Target History for Iqvia (NYSE:IQV)

Iqvia (NYSE:IQV) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/15/2018Royal Bank of CanadaSet Price TargetBuy$118.00LowView Rating Details
2/15/2018Piper Jaffray CompaniesReiterated RatingHold$103.00LowView Rating Details
2/15/2018JPMorgan Chase & Co.Boost Price TargetOverweight$115.00 -> $120.00LowView Rating Details
1/24/2018MizuhoSet Price TargetHold$97.00LowView Rating Details
1/22/2018SunTrust BanksReiterated RatingHold$110.00LowView Rating Details
1/18/2018Evercore ISIInitiated CoverageOutperform -> Outperform$112.00HighView Rating Details
12/15/2017Mitsubishi UFJ Financial GroupInitiated CoverageNeutral$112.00LowView Rating Details
11/10/2017KeyCorpReiterated RatingOverweight -> Sector Weight$100.00N/AView Rating Details
11/9/2017Morgan StanleyBoost Price TargetOverweight$96.00 -> $121.00N/AView Rating Details
10/31/2017Credit Suisse GroupReiterated RatingOutperform$115.00 -> $125.00N/AView Rating Details
10/30/2017Jefferies GroupBoost Price TargetHold$107.00 -> $110.00N/AView Rating Details
10/27/2017BarclaysBoost Price TargetOverweight$100.00 -> $120.00N/AView Rating Details
10/27/2017Stifel NicolausUpgradeHold -> Buy$92.00 -> $128.00N/AView Rating Details
10/9/2017Robert W. BairdReiterated RatingHold$98.00N/AView Rating Details
9/18/2017ArgusBoost Price TargetBuy$98.00 -> $104.00LowView Rating Details
8/7/2017CitigroupBoost Price TargetNeutral$96.00 -> $97.00LowView Rating Details
8/4/2017William BlairUpgradeMarket Perform -> Outperform$70.10 -> $93.42LowView Rating Details
2/17/2017Wells Fargo & CoUpgradeMarket Perform -> OutperformN/AView Rating Details
2/3/2017Deutsche BankDowngradeBuy -> Hold$81.00 -> $80.00N/AView Rating Details
12/16/2016Goldman Sachs GroupDowngradeBuy -> Neutral$83.00N/AView Rating Details
12/4/2016Pacific CrestSet Price TargetBuy$82.00N/AView Rating Details
12/2/2016Bank of AmericaDowngradeBuy -> Neutral$89.00N/AView Rating Details
12/1/2016Raymond James FinancialReiterated RatingStrong-Buy -> Market PerformN/AView Rating Details
7/11/2016Avondale PartnersUpgradeMarket Perform -> Outperform$62.00 -> $87.00N/AView Rating Details
(Data available from 2/18/2016 forward)

Earnings

Iqvia (NYSE:IQV) Earnings History and Estimates Chart

Earnings by Quarter for Iqvia (NYSE:IQV)

Iqvia (NYSE IQV) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018        
2/14/2018Q4 2017$1.34$1.32$2.14 billion$2.16 billionViewN/AView Earnings Details
10/26/2017Q3 2017$1.14$1.19$2.01 billion$2.02 billionViewN/AView Earnings Details
8/3/2017Q2 2017$1.05$1.09$1.96 billion$1.97 billionViewListenView Earnings Details
5/3/2017Q1 17$0.95$1.01$1.91 billion$1.91 billionViewListenView Earnings Details
2/14/2017Q416$1.05$1.09$1.97 billion$1.95 billionViewListenView Earnings Details
11/2/2016Q316$0.99$1.00$1.16 billion$1.14 billionViewN/AView Earnings Details
7/27/2016Q216$0.90$0.93$1.15 billion$1.17 billionViewListenView Earnings Details
5/3/2016Q116$0.86$0.89$1.12 billion$1.11 billionViewN/AView Earnings Details
2/11/2016Q415$0.87$0.90$1.13 billion$1.13 billionViewListenView Earnings Details
10/28/2015Q315$0.81$0.94$1.11 billion$1.09 billionViewListenView Earnings Details
7/29/2015Q215$0.70$0.78$1.05 billion$1.07 billionViewListenView Earnings Details
4/29/2015Q115$0.71$0.72$1.04 billion$1.35 billionViewN/AView Earnings Details
2/12/2015Q414$0.67$0.71$1.08 billion$1.06 billionViewN/AView Earnings Details
10/30/2014Q214$0.64$0.65$1.05 billion$1.06 billionViewN/AView Earnings Details
7/31/2014Q2$0.60$0.65$1.03 billion$1.04 billionViewN/AView Earnings Details
5/2/2014Q114$0.55$0.68$1.02 billion$1,000.00 millionViewN/AView Earnings Details
2/19/2014Q413$0.55$0.58$980.64 million$1.38 millionViewN/AView Earnings Details
10/31/2013Q313$0.50$0.54$952.14 million$1.20 billionViewN/AView Earnings Details
8/1/2013Q2 2013$0.46$0.50$942.30 million$1.30 billionViewN/AView Earnings Details
2/15/2011$0.10$0.12ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Iqvia (NYSE:IQV) Earnings Estimates

2018 EPS Consensus Estimate: $4.49
2019 EPS Consensus Estimate: $6.20
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.69$1.33$1.01
Q2 20183$0.71$1.33$1.10
Q3 20182$0.79$1.35$1.07
Q4 20183$0.94$1.54$1.31
Q1 20191$1.36$1.36$1.36
Q2 20191$1.49$1.49$1.49
Q3 20191$1.59$1.59$1.59
Q4 20191$1.76$1.76$1.76
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Iqvia (NYSE:IQV)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Iqvia (NYSE IQV) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 6.40%
Institutional Ownership Percentage: 95.91%
Insider Trades by Quarter for Iqvia (NYSE:IQV)
Institutional Ownership by Quarter for Iqvia (NYSE:IQV)

Iqvia (NYSE IQV) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/17/2018James H Erlinger IIIInsiderSell10,000$99.97$999,700.00View SEC Filing  
12/20/2017James H Erlinger IIIInsiderSell10,000$101.21$1,012,100.00View SEC Filing  
12/1/2017Ari BousbibInsiderSell46,080$101.79$4,690,483.20View SEC Filing  
11/30/2017Cpp Investment Board Private HMajor ShareholderSell7,497,807$102.00$764,776,314.00View SEC Filing  
11/30/2017John ConnaughtonDirectorSell1,163,191$102.00$118,645,482.00View SEC Filing  
11/6/2017Jack M GreenbergDirectorSell33,400$108.07$3,609,538.00View SEC Filing  
11/1/2017Ari BousbibInsiderSell46,080$108.14$4,983,091.201,036,839View SEC Filing  
10/18/2017James H Erlinger IIIInsiderSell10,000$100.51$1,005,100.0027,340View SEC Filing  
10/2/2017Ari BousbibInsiderSell46,080$94.91$4,373,452.801,036,839View SEC Filing  
9/27/2017James H Erlinger IIIInsiderSell10,000$94.52$945,200.0027,340View SEC Filing  
9/19/2017Cpp Investment Board Private HMajor ShareholderSell6,748,026$94.87$640,185,226.62View SEC Filing  
9/19/2017John ConnaughtonDirectorSell1,030,429$94.87$97,756,799.23View SEC Filing  
9/1/2017Ari BousbibInsiderSell46,080$95.65$4,407,552.001,036,839View SEC Filing  
8/28/2017Cpp Investment Board Private HMajor ShareholderSell5,218,245$97.33$507,891,785.85View SEC Filing  
8/28/2017Dennis B Ph D GillingsDirectorSell968,023$97.33$94,217,678.599,071,839View SEC Filing  
8/25/2017Kevin C KnightlyInsiderSell19,339$99.51$1,924,423.8940,650View SEC Filing  
8/9/2017Kevin C KnightlyInsiderSell20,000$90.28$1,805,600.0046,826View SEC Filing  
8/7/2017Ari BousbibInsiderSell92,160$90.35$8,326,656.001,082,919View SEC Filing  
5/31/2017Cpp Investment Board Private HMajor ShareholderSell7,131,165$84.01$599,089,171.65View SEC Filing  
5/31/2017Dennis B Ph D GillingsDirectorSell860,000$84.01$72,248,600.0010,002,230View SEC Filing  
5/30/2017John G DanhaklDirectorSell761,143$84.01$63,943,623.43View SEC Filing  
5/17/2017Jack M GreenbergDirectorSell6,092$82.50$502,590.002,930View SEC Filing  
11/21/2016Jack M GreenbergDirectorSell2,000$79.77$159,540.002,930View SEC Filing  
6/9/2016Kevin K GordonCOOSell24,000$66.41$1,593,840.0041,899View SEC Filing  
6/7/2016Corp 3IMajor ShareholderSell2,250,000$66.10$148,725,000.00View SEC Filing  
5/12/2016Annie H LoDirectorBuy502$64.80$32,529.602,062View SEC Filing  
5/10/2016Kevin K GordonCOOSell24,000$67.42$1,618,080.0041,899View SEC Filing  
4/12/2016Kevin K GordonCOOSell24,000$69.44$1,666,560.0041,899View SEC Filing  
3/22/2016Kevin K GordonCOOSell3,639$65.01$236,571.3921,538View SEC Filing  
3/18/2016Kevin K GordonCOOSell20,361$65.01$1,323,668.6119,950View SEC Filing  
3/1/2016Kevin K. GordonCOOSell24,000$65.03$1,560,720.0041,899View SEC Filing  
9/2/2015Charles Edward WilliamsSVPSell5,000$72.43$362,150.002,071View SEC Filing  
5/19/2015Dennis B Ph D GillingsMajor ShareholderSell2,503,123$64.85$162,327,526.55View SEC Filing  
5/19/2015Tpg Advisors V, Inc.InsiderSell2,251,719$64.85$146,023,977.15View SEC Filing  
3/25/2015Michael J EvaniskoDirectorSell2,500$67.10$167,750.00View SEC Filing  
2/2/2015Kevin K GordonCFOSell25,000$60.19$1,504,750.00View SEC Filing  
1/7/2015Michael J EvaniskoDirectorSell2,500$57.86$144,650.00View SEC Filing  
1/2/2015Kevin K GordonCFOSell25,000$59.16$1,479,000.00View SEC Filing  
12/11/2014Jack M GreenbergDirectorSell23,508$57.29$1,346,773.32View SEC Filing  
12/1/2014Kevin K GordonCFOSell25,000$56.77$1,419,250.00View SEC Filing  
11/10/2014Dennis B Ph D GillingsMajor ShareholderSell3,566,187$58.09$207,159,802.83View SEC Filing  
11/7/2014Michael J EvaniskoDirectorSell2,500$57.50$143,750.00View SEC Filing  
11/3/2014Kevin K GordonCFOSell25,000$59.00$1,475,000.00View SEC Filing  
7/2/2014Michael J EvaniskoDirectorSell5,000$54.00$270,000.00View SEC Filing  
5/27/2014Tpg Advisors Iii, Inc.Major ShareholderSell3,287,209$50.23$165,116,508.07View SEC Filing  
3/26/2014Christopher GordonDirectorSell570,682$50.31$28,711,011.42View SEC Filing  
3/26/2014Dennis Ph Gillingsmajor shareholderSell570,681$50.31$28,710,961.1116,609,827View SEC Filing  
3/18/2014Mireille Phd GillingsDirectorSell3,304,542$50.31$166,251,508.02View SEC Filing  
3/18/2014Tpg Advisors Iii, Inc.major shareholderSell3,564,119$50.31$179,310,826.89View SEC Filing  
1/17/2014Derek WinstanlyVPSell60,000$50.00$3,000,000.00229,500View SEC Filing  
1/16/2014Michael EvaniskoDirectorSell5,000$50.00$250,000.0015,400View SEC Filing  
1/10/2014Derek WinstanlyVPSell60,000$48.00$2,880,000.00229,500View SEC Filing  
12/20/2013Derek WinstanlyVPSell60,000$46.00$2,760,000.00229,500View SEC Filing  
12/10/2013Derek WinstanlyVPSell60,000$44.00$2,640,000.00229,500View SEC Filing  
11/20/2013Michael EvaniskoDirectorSell8,000$43.00$344,000.0020,400View SEC Filing  
11/18/2013John RatliffCOOSell212,140$42.55$9,026,557.00View SEC Filing  
11/18/2013Michael MortimerVPSell200,000$42.55$8,510,000.0025,000View SEC Filing  
5/14/2013Group Holdings (Sbs) Advis TpgMajor ShareholderSell3,944,899$37.80$149,117,182.20View SEC Filing  
5/14/2013Mireille GillingsDirectorSell2,257,805$37.80$85,345,029.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Iqvia (NYSE IQV) News Headlines

Source:
DateHeadline
Royal Bank of Canada Analysts Give Iqvia (IQV) a $118.00 Price TargetRoyal Bank of Canada Analysts Give Iqvia (IQV) a $118.00 Price Target
www.americanbankingnews.com - February 16 at 8:46 PM
Analysts Issue Forecasts for Iqvia Holdings Incs Q1 2019 Earnings (IQV)Analysts Issue Forecasts for Iqvia Holdings Inc's Q1 2019 Earnings (IQV)
www.americanbankingnews.com - February 16 at 2:20 PM
Research Analysts Set Expectations for Iqvia Holdings Incs Q2 2018 Earnings (IQV)Research Analysts Set Expectations for Iqvia Holdings Inc's Q2 2018 Earnings (IQV)
www.americanbankingnews.com - February 16 at 8:58 AM
IQVIA Holdings, Inc. 2017 Q4 - Results - Earnings Call SlidesIQVIA Holdings, Inc. 2017 Q4 - Results - Earnings Call Slides
seekingalpha.com - February 15 at 4:46 PM
Iqvia (IQV) Receives Hold Rating from Piper Jaffray CompaniesIqvia (IQV) Receives Hold Rating from Piper Jaffray Companies
www.americanbankingnews.com - February 15 at 4:30 PM
Iqvia (IQV) Given New $120.00 Price Target at JPMorgan Chase & Co.Iqvia (IQV) Given New $120.00 Price Target at JPMorgan Chase & Co.
www.americanbankingnews.com - February 15 at 12:00 PM
KeyCorp Analysts Lift Earnings Estimates for Iqvia Holdings Inc (IQV)KeyCorp Analysts Lift Earnings Estimates for Iqvia Holdings Inc (IQV)
www.americanbankingnews.com - February 15 at 8:48 AM
Should You Buy IQVIA (IQV) Ahead of Earnings? - Yahoo FinanceShould You Buy IQVIA (IQV) Ahead of Earnings? - Yahoo Finance
finance.yahoo.com - February 15 at 8:34 AM
IQVIA Reports Fourth-Quarter and Full-Year 2017 Results, Issues First-Quarter and Full-Year 2018 Guidance - Business Wire (press release)IQVIA Reports Fourth-Quarter and Full-Year 2017 Results, Issues First-Quarter and Full-Year 2018 Guidance - Business Wire (press release)
www.businesswire.com - February 15 at 8:34 AM
IQVIA Holdings (IQV) CEO Ari Bousbib on Q4 2017 Results - Earnings Call TranscriptIQVIA Holdings' (IQV) CEO Ari Bousbib on Q4 2017 Results - Earnings Call Transcript
seekingalpha.com - February 14 at 4:57 PM
Iqvia (IQV) Announces Quarterly  Earnings Results, Beats Expectations By $0.06 EPSIqvia (IQV) Announces Quarterly Earnings Results, Beats Expectations By $0.06 EPS
www.americanbankingnews.com - February 14 at 11:12 AM
Iqvia (IQV) Issues Q1 Earnings GuidanceIqvia (IQV) Issues Q1 Earnings Guidance
www.americanbankingnews.com - February 14 at 9:04 AM
Iqvia (IQV) Releases FY18 Earnings GuidanceIqvia (IQV) Releases FY18 Earnings Guidance
www.americanbankingnews.com - February 14 at 9:04 AM
Form 4 IQVIA HOLDINGS INC. For: Feb 08 Filed by: BOUSBIB ARIForm 4 IQVIA HOLDINGS INC. For: Feb 08 Filed by: BOUSBIB ARI
www.streetinsider.com - February 13 at 4:16 PM
Should You Buy IQVIA (IQV) Ahead of Earnings?Should You Buy IQVIA (IQV) Ahead of Earnings?
www.zacks.com - February 13 at 9:25 AM
Iqvia (IQV) Set to Announce Quarterly Earnings on WednesdayIqvia (IQV) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - February 7 at 4:38 AM
Iqvia Holdings Inc (IQV) Expected to Announce Quarterly Sales of $2.14 BillionIqvia Holdings Inc (IQV) Expected to Announce Quarterly Sales of $2.14 Billion
www.americanbankingnews.com - February 7 at 2:48 AM
IQVIA to Lead Group to Expand Safety/Efficacy Monitoring of Regulated Vaccines and Biologics for the FDA Center for Biologics Evaluation and ResearchIQVIA to Lead Group to Expand Safety/Efficacy Monitoring of Regulated Vaccines and Biologics for the FDA Center for Biologics Evaluation and Research
finance.yahoo.com - February 6 at 4:16 PM
 Brokerages Anticipate Iqvia Holdings Inc (IQV) to Announce $1.34 Earnings Per Share Brokerages Anticipate Iqvia Holdings Inc (IQV) to Announce $1.34 Earnings Per Share
www.americanbankingnews.com - February 5 at 11:14 PM
Iqvia Holdings Inc (IQV) Receives Average Recommendation of "Buy" from AnalystsIqvia Holdings Inc (IQV) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - February 2 at 7:42 PM
IQVIA to Announce Fourth-Quarter 2017 Results and Issue 2018 Guidance on February 14, 2018 - Business Wire (press release)IQVIA to Announce Fourth-Quarter 2017 Results and Issue 2018 Guidance on February 14, 2018 - Business Wire (press release)
www.businesswire.com - February 2 at 9:20 AM
IQVIA to Announce Fourth-Quarter 2017 Results and Issue 2018 Guidance on February 14, 2018IQVIA to Announce Fourth-Quarter 2017 Results and Issue 2018 Guidance on February 14, 2018
finance.yahoo.com - February 1 at 9:25 AM
Mizuho Reiterates $97.00 Price Target for Iqvia (IQV)Mizuho Reiterates $97.00 Price Target for Iqvia (IQV)
www.americanbankingnews.com - January 24 at 11:52 PM
FY2017 Earnings Estimate for Iqvia Holdings Inc (IQV) Issued By SunTrust BanksFY2017 Earnings Estimate for Iqvia Holdings Inc (IQV) Issued By SunTrust Banks
www.americanbankingnews.com - January 23 at 8:54 AM
Teva Pharmaceutical Industries Ltd -- Moodys: European generic drug market growth to continue into 2020 on patent expiries, rising usageTeva Pharmaceutical Industries Ltd -- Moody's: European generic drug market growth to continue into 2020 on patent expiries, rising usage
finance.yahoo.com - January 23 at 8:03 AM
$2.14 Billion in Sales Expected for Iqvia Holdings Inc (IQV) This Quarter$2.14 Billion in Sales Expected for Iqvia Holdings Inc (IQV) This Quarter
www.americanbankingnews.com - January 22 at 2:20 PM
Iqvia (IQV) Receives Hold Rating from SunTrust BanksIqvia (IQV) Receives Hold Rating from SunTrust Banks
www.americanbankingnews.com - January 22 at 12:46 PM
Iqvia (IQV) Rating Lowered to Hold at Zacks Investment ResearchIqvia (IQV) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - January 21 at 11:28 AM
IQVIA Named to FORTUNEs 2018 List of “Worlds Most Admired Companies” - Business Wire (press release)IQVIA Named to FORTUNE's 2018 List of “World's Most Admired Companies” - Business Wire (press release)
www.businesswire.com - January 20 at 8:27 AM
Zacks: Brokerages Anticipate Iqvia Holdings Inc (IQV) Will Announce Earnings of $1.34 Per ShareZacks: Brokerages Anticipate Iqvia Holdings Inc (IQV) Will Announce Earnings of $1.34 Per Share
www.americanbankingnews.com - January 20 at 3:16 AM
Insider Selling: Iqvia Holdings Inc (IQV) Insider Sells 10,000 Shares of StockInsider Selling: Iqvia Holdings Inc (IQV) Insider Sells 10,000 Shares of Stock
www.americanbankingnews.com - January 19 at 9:32 PM
Evercore ISI Begins Coverage on Iqvia (IQV)Evercore ISI Begins Coverage on Iqvia (IQV)
www.americanbankingnews.com - January 18 at 5:28 PM
Medical Laboratories and Research Stocks Research Reports Released on Agilent Technologies, IQVIA Holdings ... - PR Newswire (press release)Medical Laboratories and Research Stocks' Research Reports Released on Agilent Technologies, IQVIA Holdings ... - PR Newswire (press release)
www.prnewswire.com - January 16 at 8:29 AM
William Blair Equities Analysts Raise Earnings Estimates for Iqvia Holdings Inc (IQV)William Blair Equities Analysts Raise Earnings Estimates for Iqvia Holdings Inc (IQV)
www.americanbankingnews.com - January 15 at 7:42 AM
Iqvia Holdings Inc (IQV) to Post Q1 2018 Earnings of $1.24 Per Share, William Blair ForecastsIqvia Holdings Inc (IQV) to Post Q1 2018 Earnings of $1.24 Per Share, William Blair Forecasts
www.americanbankingnews.com - January 12 at 10:02 AM
Head to Head Survey: Iqvia (IQV) versus Its PeersHead to Head Survey: Iqvia (IQV) versus Its Peers
www.americanbankingnews.com - January 9 at 5:38 PM
Reviewing Iqvia (IQV) & Its PeersReviewing Iqvia (IQV) & Its Peers
www.americanbankingnews.com - January 9 at 5:10 AM
Iqvia Holdings Inc (IQV) Given Consensus Rating of "Buy" by BrokeragesIqvia Holdings Inc (IQV) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - January 8 at 5:34 PM
Head to Head Review: Iqvia (IQV) vs. The CompetitionHead to Head Review: Iqvia (IQV) vs. The Competition
www.americanbankingnews.com - January 8 at 3:30 AM
Iqvia (IQV) & Its Competitors Critical ComparisonIqvia (IQV) & Its Competitors Critical Comparison
www.americanbankingnews.com - January 6 at 1:36 PM
ETFs with exposure to IQVIA Holdings, Inc. : January 1, 2018ETFs with exposure to IQVIA Holdings, Inc. : January 1, 2018
finance.yahoo.com - January 1 at 6:18 PM
IQVIA Holdings Enters Oversold Territory (IQV) - NasdaqIQVIA Holdings Enters Oversold Territory (IQV) - Nasdaq
www.nasdaq.com - December 23 at 8:58 AM
Iqvia Holdings Inc (IQV) Insider Sells $1,012,100.00 in StockIqvia Holdings Inc (IQV) Insider Sells $1,012,100.00 in Stock
www.americanbankingnews.com - December 22 at 5:38 PM
Head to Head Contrast: Iqvia (IQV) & The CompetitionHead to Head Contrast: Iqvia (IQV) & The Competition
www.americanbankingnews.com - December 21 at 5:12 PM
Iqvia (IQV) versus Its Peers Financial SurveyIqvia (IQV) versus Its Peers Financial Survey
www.americanbankingnews.com - December 21 at 11:24 AM
Market Trends Toward New Normal in Ashland Global, BioCryst Pharmaceuticals, PICO, Chicago Rivet & Machine, Mercury General, and IQVIA Holdings — Emerging Consolidated Expectations, Analyst RatingsMarket Trends Toward New Normal in Ashland Global, BioCryst Pharmaceuticals, PICO, Chicago Rivet & Machine, Mercury General, and IQVIA Holdings — Emerging Consolidated Expectations, Analyst Ratings
finance.yahoo.com - December 20 at 8:17 AM
ETFs with exposure to IQVIA Holdings, Inc. : December 19, 2017ETFs with exposure to IQVIA Holdings, Inc. : December 19, 2017
finance.yahoo.com - December 19 at 6:22 PM
IQVIA Holdings, Inc. :IQV-US: Earnings Analysis: Q3, 2017 By the Numbers : December 18, 2017IQVIA Holdings, Inc. :IQV-US: Earnings Analysis: Q3, 2017 By the Numbers : December 18, 2017
finance.yahoo.com - December 18 at 6:30 PM
Iqvia (IQV) Lifted to "B" at TheStreetIqvia (IQV) Lifted to "B" at TheStreet
www.americanbankingnews.com - December 15 at 7:48 PM
Iqvia (IQV) Now Covered by Mitsubishi UFJ Financial GroupIqvia (IQV) Now Covered by Mitsubishi UFJ Financial Group
www.americanbankingnews.com - December 15 at 9:58 AM

SEC Filings

Iqvia (NYSE:IQV) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Iqvia (NYSE:IQV) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Iqvia (NYSE IQV) Stock Chart for Sunday, February, 18, 2018

Loading chart…

This page was last updated on 2/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.